Skip to content

Remotely Monitored Exercise Program in Pregnant Women With Obesity

Remotely Monitored and Exercise Program in Gestational Weight Gain in Pregnant Women With Obesity

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05331586
Acronym
GROB
Enrollment
40
Registered
2022-04-15
Start date
2022-07-31
Completion date
2023-05-31
Last updated
2022-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Maternal, Pregnancy Related

Keywords

Obesity, pregnancy, exercise, physical activity, maternal, gestational weight gain, gestational diabetes mellitus

Brief summary

Pregnant women with obesity will be invited to participate in structured home-based exercise programme, remotely monitored

Detailed description

Pregnant women with obesity will be invited to participate in structured home-based exercise programme, remotely monitored. The remote system use inertial motion trackers, digitizes pregnant women motion and provides real-time feedback on performance through a mobile app. It also includes a web-based platform that allows the clinical team to prescribe, monitor and adapt the exercise program remotely. This way, the system allows patients to perform independent exercise program at home without the need for constant therapist supervision, ensuring remote monitoring throughout the rehabilitation program. The exercise programme will be performed since the first gestational trimester until delivery. Data of gestational weight gain, gestational diabetes mellitus, low back pain and quality of life will be colected.

Interventions

BEHAVIORALRemote Exercise

The pregnant women will perform a home-based structured exercise programme. The exercise will be remotely monitored since the first gestational trimester until delivery

Sponsors

Fundação para a Ciência e a Tecnologia
CollaboratorOTHER
Universidade do Porto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Pregnant women with obesity (BMI ≥ 30 kg/m2) at first gestational trimester

Exclusion criteria

* pre-pregnancy BMI \< 30 kg/m2; * previous bariatric surgery; * hemodynamically significant heart disease; * restrictive lung disease; * incompetent cervix or cerclage; * multiple gestation; * persistent second- or third-trimester bleeding; * placenta previa after 26 weeks of gestation; * premature labor during the current pregnancy; * ruptured membranes; * preeclampsia or pregnancy-induced hypertension; * severe anemia; * inability to read and understand Portuguese; -\>15 weeks gestation.

Design outcomes

Primary

MeasureTime frameDescription
Gestational Weight GainAt deliveryUsing portable digital scale (Tantita InnerScan BC-545). Gestational weight gain will be calculated as the difference between maternal weight at last appointment (36-39 gestational weeks) and pre-pregnancy weight.
Excessive gestational weight gainAt deliveryThe adequate gestational weight gain in pregnant women with obesity should not exceed 9kg in entire pregnancy, the values over these thresholds will be considered excessive gestational weight gain.

Secondary

MeasureTime frameDescription
Objective Physical Activity assessmentAt first, second and third gestational trimesterAccelerometry, is a device that monitors the acceleration of body segments, it is considered the gold standard with regard to objectivity and reliability (ICC:0.661-0.806)
Gestational Diabetes MellitusSecond gestational trimesterThe presence of gestational diabetes mellitus will be assessed between 24-28 gestation weeks, through the Oral Glucose Tolerance Test. Blood sampling for fasting glucose concentrations will be taken after a 10 hour overnight fast, and glucose tolerance will measured by a 2 hours 75 mg per-oral glucose tolerance test. GDM will be diagnosed as fasting glucose ≥ 126 mg/dl or 2h concentration ≥ 200 mg/dl.
Low Back PainAt first, second and third gestational trimesterOswestry Low Back Pain Disability Questionnaire (ODI v2.0)
Pelvic Floor and sexual disorders during pregnancyAt first, second and third gestational trimesterAssessment of Pelvic Floor Disorders and Their Risk Factors During Pregnancy and Postpartum Questionnaire
Quality of Life AssessmentAt first, second and third gestational trimesterCOOP-Quality of life during Pregnancy Questionnaire
Subjective Physical Activity assessmentAt first, second and third gestational trimesterPregnancy Physical Activity Questionnaire (PPAQ) is a self-reported questionnaire. The objective is measure the type and intensity of pregnant women physical activity.

Countries

Portugal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026